Gerald Clarke | 09/18/2013
Is part of the problem in the lack of correlation between in vivo reults to in vitro results a poor choice of cell models? We spoke to Sandi Engle Senior Principal Scientist at Pfizer Global Research about the promise held by using stem cell derived cells as models for human disease.
To continue reading this story Click Here
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More